Noetic Fund

Developing small-molecule drug compounds for mental disorders.

#Small-molecule therapeutics / biotech

Developing sub-perceptual, non-hallucinogenic treatments based on psychedelic compounds.

#Psychedelic-based therapeutics / biotech

Focus on serotonin 2A receptor agonists with mitigation of psychoactivity.

#Psychedelic therapeutics / biotech

Develops novel medicines harnessing therapeutic promise of psychedelics.

#Psychedelic-inspired medicines / biotech

Described as harnessing AI for educators.

#AI for education / digital health

Clinical-stage company developing psychedelic-inspired medicines including psilocybin, LSD, MDMA, DMT and 18-MC.

#Psychedelic-inspired medicines / clinical-stage biotech

Operating company addressing mental health and wellness; listed as exited on site.

#Mental health / wellness services

Provides end-to-end clinical research services focused on psychedelic and alternative medicines.

#Clinical research services / evidence generation

Developing biosynthetic psychoactive compounds; noted TSXV:PSYB.

#Biosynthetic psychoactive compounds / biotech

Manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications.

#Pharmaceutical-grade manufacturing for psychedelic research

Developed a pain and sleep management mask.

#Device / pain and sleep management

Developing gentler MDMA-like medicines for prescription mental wellness.

#Psychedelic-like therapeutics / biotech

Pipeline aimed at neurological and psychiatric disorders and an imaging software device.

#Neurological and psychiatric therapeutics / imaging software device

In-home wellness tracker that identifies individual physiological needs.

#In-home wellness tracking / digital health

Works on clinical immersions and functional mushroom supplements.

#Fungi and plant medicine / supplements

Holding company that creates and supports early-stage psychedelic and wellness companies.

#Holding company / early-stage psychedelic & wellness companies

Raised US$5.5M seed stage financing to advance lead therapeutic for cognitive symptoms associated with depression and aging.

#Therapeutics for cognitive deficits / biotech

Noetic led the Seed round; ASRI focuses on design, synthesis, and pharmacological evaluation of novel compounds from the Shulgin Vault.

#Psychedelic drug discovery and development